Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
TipRanks Clinical-Trials-Auto-Generated Newsdesk
TipRanks Reporter
TipRanks’s Recent Articles
Bayer AG’s Regorafenib Study: A Potential Game-Changer in Cancer Treatment
Bayer AG (($BAYRY)), Bayer Ag (UK) (($GB:0P6S)) announced an update on their ongoing clinical study. Study Overview: Bayer...
4d ago
AbbVie’s Ubrogepant Study: A Potential Game-Changer for Pediatric Migraine Treatment
Abbvie (($ABBV)), Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 3...
4d ago
ABBV
Sanofi’s Teplizumab Study: A Closer Look at Real-World Impact on Type 1 Diabetes
Sanofi SA (($SNY)), Sanofi (($DE:SNW)), Sanofi (($SNYNF)) announced an update on their ongoing clinical study. Sanofi’s recent clinical...
4d ago
SNY
Regeneron and Intellia’s Gene Therapy Study for Hemophilia B: A Potential Game Changer
Regeneron Pharmaceuticals (($REGN)), Intellia Therapeutics Inc (($NTLA)) announced an update on their ongoing clinical study. Regeneron Pharmaceuticals and...
4d ago
NTLA
REGN
AstraZeneca’s Real-World Study on Acalabrutinib in Romania: Key Insights for Investors
AstraZeneca (($AZN)), AstraZeneca plc (($GB:AZN)), AstraZeneca (($DE:ZEGA)), AstraZeneca plc US (($AZNCF)) announced an update on their ongoing clinical...
4d ago
AZN
Bristol-Myers Squibb’s Innovative Cancer Study: A Potential Game-Changer?
Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers Squibb is conducting...
4d ago
BMY
AstraZeneca’s Innovative Approach in Cancer Treatment: A Study Update
AstraZeneca (($AZN)), AstraZeneca plc (($GB:AZN)), AstraZeneca (($DE:ZEGA)), AstraZeneca plc US (($AZNCF)) announced an update on their ongoing clinical...
4d ago
AZN
AstraZeneca’s APPRECIATE Study: A New Hope for APOL1-Mediated Kidney Disease
AstraZeneca (($AZN)), AstraZeneca plc (($GB:AZN)), AstraZeneca (($DE:ZEGA)), AstraZeneca plc US (($AZNCF)) announced an update on their ongoing clinical...
4d ago
AZN
BioNTech’s Phase II Study on BNT327: A Potential Game-Changer in Lung Cancer Treatment
Biontech Se Sponsored Adr (($BNTX)), Biontech SE (($CC:BNTX.CUR)) announced an update on their ongoing clinical study. BioNTech SE...
4d ago
BNTX
Sanofi’s Phase 3 Study on Belumosudil for CLAD: A Potential Game-Changer
Sanofi SA (($SNY)), Sanofi (($SNYNF)), Sanofi (($DE:SNW)) announced an update on their ongoing clinical study. Sanofi is conducting...
4d ago
SNY
Rhythm Pharmaceuticals Advances Genetic Obesity Treatment with Setmelanotide Study
Rhythm Pharmaceuticals (($RYTM)) announced an update on their ongoing clinical study. Rhythm Pharmaceuticals is conducting a Phase 3...
4d ago
RYTM
Rhythm Pharmaceuticals’ RM-718 Study: A Potential Game-Changer in Obesity Treatment
Rhythm Pharmaceuticals (($RYTM)) announced an update on their ongoing clinical study. Rhythm Pharmaceuticals is conducting a study titled...
4d ago
RYTM
Pfizer’s Promising Study on PF-07248144: A Potential Game-Changer in Cancer Treatment
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a clinical study...
4d ago
PFE
Regeneron’s Cemiplimab: A New Hope for Early-Stage Skin Cancer?
Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Study Overview: Regeneron Pharmaceuticals is conducting a...
4d ago
REGN
Bayer AG Advances Parkinson’s Treatment with Promising Gene Therapy Study
Bayer AG (($BAYRY)), Bayer Ag (UK) (($GB:0P6S)) announced an update on their ongoing clinical study. Study Overview: Bayer...
4d ago
AstraZeneca’s CAR-T Therapy Study: A New Hope for Hepatocellular Carcinoma
AstraZeneca (($AZN)), AstraZeneca plc (($GB:AZN)), AstraZeneca (($DE:ZEGA)), AstraZeneca plc US (($AZNCF)) announced an update on their ongoing clinical...
4d ago
AZN
Sanofi’s New Phase 2a Study: A Potential Game-Changer in Kidney Disease Treatment
Sanofi SA (($SNY)), Sanofi (($SNYNF)), Sanofi (($DE:SNW)) announced an update on their ongoing clinical study. Sanofi SA has...
4d ago
SNY
BioNTech’s New Study on Breast Cancer Treatment: A Potential Game-Changer?
Biontech Se Sponsored Adr (($BNTX)), Biontech SE (($CC:BNTX.CUR)) announced an update on their ongoing clinical study. BioNTech SE...
4d ago
BNTX
AstraZeneca’s CAPItello-292 Study: A New Frontier in Breast Cancer Treatment
AstraZeneca (($AZN)), AstraZeneca plc (($GB:AZN)), AstraZeneca (($DE:ZEGA)), AstraZeneca plc US (($AZNCF)) announced an update on their ongoing clinical...
4d ago
AZN
AstraZeneca’s Promising Phase III Study on AZD0901 for Advanced Gastric Cancer
AstraZeneca (($AZN)), AstraZeneca plc (($GB:AZN)), AstraZeneca (($DE:ZEGA)), AstraZeneca plc US (($AZNCF)) announced an update on their ongoing clinical...
4d ago
AZN
Sanofi’s Dupilumab Study: A Closer Look at Long-term Treatment for Prurigo Nodularis
Sanofi SA (($SNY)), Sanofi (($DE:SNW)), Sanofi (($SNYNF)) announced an update on their ongoing clinical study. Sanofi is conducting...
4d ago
SNY
Sanofi’s Phase 3 Study on Frexalimab: A Potential Game-Changer for Multiple Sclerosis Treatment
Sanofi SA (($SNY)), Sanofi (($DE:SNW)), Sanofi (($SNYNF)) announced an update on their ongoing clinical study. Sanofi is currently...
4d ago
SNY
Pfizer’s Latest Study on HER2-positive Breast Cancer: Key Insights for Investors
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a study titled...
4d ago
PFE
Bayer’s SMART-Finder Study: A Closer Look at T2DM and Kidney Health
Bayer AG (($BAYRY)), Bayer Ag (UK) (($GB:0P6S)) announced an update on their ongoing clinical study. Study Overview: Bayer...
4d ago
Incyte’s Ruxolitinib Cream Study Completes: A Potential Game-Changer for Prurigo Nodularis Treatment
Incyte Corporation (($CC:INCY.CUR)) announced an update on their ongoing clinical study. Incyte Corporation has recently completed a clinical...
4d ago
Biogen’s New Clinical Trial: A Potential Game-Changer for Kidney Transplant Patients
Biogen Inc. (($BIIB)), Biogen (($CC:HTER)) announced an update on their ongoing clinical study. Biogen Inc. has initiated a...
4d ago
BIIB
Pfizer’s New Cancer Treatment Study: A Potential Game Changer?
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a study titled...
4d ago
PFE
AstraZeneca’s Anifrolumab Pregnancy Study: A New Chapter in SLE Treatment
AstraZeneca (($AZN)), AstraZeneca plc (($GB:AZN)), AstraZeneca (($DE:ZEGA)), AstraZeneca plc US (($AZNCF)) announced an update on their ongoing clinical...
4d ago
AZN
Pfizer’s New Study on Eczema Treatment: What Investors Need to Know
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Phase 1...
4d ago
PFE
Edwards Lifesciences’ TRISCEND II Trial: A Game-Changer in Tricuspid Valve Treatment?
Edwards Lifesciences Corp. (($EW)) announced an update on their ongoing clinical study. Edwards Lifesciences Corp. is conducting the...
4d ago
EW
Sanofi’s New Study on Rilzabrutinib: A Potential Breakthrough for ITP Treatment
Sanofi SA (($SNY)), Sanofi (($SNYNF)), Sanofi (($DE:SNW)) announced an update on their ongoing clinical study. Sanofi has announced...
4d ago
SNY
Edwards Lifesciences’ ENCIRCLE Trial: A New Hope for Mitral Regurgitation Patients
Edwards Lifesciences Corp. (($EW)) announced an update on their ongoing clinical study. The ENCIRCLE Trial, officially titled ‘SAPIEN...
4d ago
EW
Regeneron Advances in Cancer Treatment with SNS-101 Study Update
Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Regeneron Pharmaceuticals, in collaboration with Sensei Biotherapeutics,...
4d ago
REGN
AstraZeneca’s LATIFY Study: A New Hope for NSCLC Treatment?
AstraZeneca (($AZN)), Parexel International (($PRXL)), AstraZeneca plc (($GB:AZN)), AstraZeneca (($DE:ZEGA)), AstraZeneca plc US (($AZNCF)) announced an update on...
4d ago
AZN
PRXL
Sanofi’s Latest Clinical Trial: A New Hope for Advanced Solid Tumors?
Sanofi SA (($SNY)), Sanofi (($SNYNF)), Sanofi (($DE:SNW)) announced an update on their ongoing clinical study. Study Overview: The...
4d ago
SNY
Pfizer’s Latest Clinical Trial: A New Hope for KRAS-Mutated Tumors
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Study Overview: Pfizer Inc. is conducting a...
4d ago
PFE
Pfizer’s Tukysa Study: A Closer Look at Its Korean Market Impact
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. has initiated a study titled...
4d ago
PFE
AstraZeneca’s Asthma Study: Key Insights for Investors
AstraZeneca (($AZN)), Parexel International (($PRXL)), AstraZeneca plc (($GB:AZN)), AstraZeneca (($DE:ZEGA)), AstraZeneca plc US (($AZNCF)) announced an update on...
4d ago
AZN
PRXL
EyePoint Pharmaceuticals Completes Promising Study on EYP-1901 for Diabetic Retinopathy
Eyepoint Pharma (($EYPT)) announced an update on their ongoing clinical study. EyePoint Pharmaceuticals has recently completed a Phase...
4d ago
EYPT
Pfizer’s PREVENAR 20 Vaccine Study: A Safety Investigation in Infants
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Study Overview: Pfizer Inc. is conducting a...
4d ago
PFE
GSK and iTeos Advance Immunotherapy Study for Lung Cancer
GlaxoSmithKline (($GSK)), GlaxoSmithKline plc (UK) (($GB:GSK)), Iteos Therapeutics, Inc. (($ITOS)) announced an update on their ongoing clinical study....
4d ago
GSK
ITOS
Celltrion’s Promising Multiple Myeloma Study: A Market Game-Changer?
Celltrion (($CONIF)) announced an update on their ongoing clinical study. Study Overview: The study titled A Double-Blind, Randomized,...
4d ago
CONIF
Incyte’s Phase 1 Study on INCB160058: A Potential Game-Changer in Myeloproliferative Neoplasms
Incyte Corporation (($CC:INCY.CUR)) announced an update on their ongoing clinical study. Incyte Corporation is currently conducting a Phase...
4d ago
Karuna Therapeutics Advances Alzheimer’s Psychosis Treatment with KarXT Study
Karuna Therapeutics, Inc. (($KRTX)) announced an update on their ongoing clinical study. Karuna Therapeutics, Inc. is conducting a...
4d ago
KRTX
Pfizer’s New Study on Disitamab Vedotin: A Potential Game-Changer in Advanced Breast Cancer Treatment
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a clinical study...
4d ago
PFE
Pfizer’s Real-World Study on Abrocitinib: Implications for Investors
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is currently conducting a study...
4d ago
PFE
Actelion’s Selexipag Study: A New Hope for Pediatric PAH
Actelion (($ALIOF)) announced an update on their ongoing clinical study. Actelion is conducting a Phase 2 clinical study...
4d ago
ALIOF
Pfizer’s Phase 1 Study on PF-08046031: A New Hope for Advanced Melanoma and Solid Tumors
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting an open-label Phase...
4d ago
PFE
Bristol-Myers Squibb’s Promising Phase 3 Alzheimer’s Study: A Potential Game-Changer
Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers Squibb is conducting...
4d ago
BMY
Bristol-Myers Squibb’s New Study on NSCLC Treatment: Market Implications
Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Bristol-Myers Squibb Company (BMY) has announced...
4d ago
BMY
SHOW MORE
You need to enable JavaScript to run this app.
